期刊文献+

超敏肌钙蛋白I检测在糖尿病心肌损伤早期诊断中的价值 被引量:8

Value of high-sensitive troponin I detection in the diagnosis of early myocardial injury
下载PDF
导出
摘要 目的探讨超敏肌钙蛋白I(hs-cTnI)在糖尿病心肌损伤早期诊断中的临床价值。方法选取240例2型糖尿病(T2DM)组及40例健康对照组,检测2组研究对象的糖化血红蛋白(HbA1c)、天门冬氨酸氨基转移酶(AST)、肌酸激酶(CK)、肌酸激酶同工酶(CK-MB)及hs-cTnI水平。结果 T2DM组血清hs-cTnI水平显著高于健康对照组(P<0.05),血清AST、CK及CK-MB水平与健康对照组比较,差异无统计学意义(P>0.05);HbA1c≥6.5%组hs-cTnI水平及升高率显著高于HBA1c≤6.4%组(P<0.05),AST、CK、CK-MB水平及升高率在2组间差异无统计学意义(P>0.05);T2DM组HbA1c与血清hs-cTnI呈正相关(r=0.471,P<0.05)。结论 hs-cTnI诊断T2DM患者早期心肌损伤具有重要的临床价值,且hs-cTnI与HbA1c呈正相关,值得临床关注。 Objective To explore the clinical value of high-sensitive troponin I detection in the diagnosis of early myocardial injury.Methods Totally 240 type 2diabetes mellitus(T2DM)patients(study group)and 40 healthy people(healthy control group)were chosen as subjects.The serum level of HbA1 c,AST,CK,CK-MB and hs-cTnI were measured among the two groups,respectively.Results Hs-cTnI level in T2 DM group was significantly higher than in healthy control group(P〈0.05),and AST,CK and CK-MB levels in two groups had no significant difference(P〉0.05).Hs-cTnI level and positive rate in HbA1c≥6.5% group was significantly higher than in HbA1c≤6.4% group(P〈0.05),and no significant difference of AST,CK and CK-MB levels and positive rate were observed in two groups(P〉0.05).There was a positive correlation between the level of HbA1 c and that of serum hscTnI in T2 DM group(r=0.471,P〈0.05).Conclusion The hs-cTnI level detection has important clinical value in the diagnosis of early myocardial injury in T2 DM patients,and HbA1 cis positively correlated with hs-cTnI.
出处 《国际检验医学杂志》 CAS 2016年第19期2670-2671,2674,共3页 International Journal of Laboratory Medicine
基金 南京军区医学创新课题(15MS076)
关键词 超敏肌钙蛋白I 2型糖尿病 心肌损伤 糖化血红蛋白 high-sensitive troponin I type 2 diabetes mellitus myocardial injury HbA1c
  • 相关文献

参考文献4

二级参考文献31

  • 1杨旭.超敏肌钙蛋白Ⅰ对于急性心肌梗死患者临床检测意义研究[J].黑龙江医学,2013,37(9):804-805. 被引量:1
  • 2姚雯颖.联合定量检测急性心肌梗死标志物在诊断中的价值[J].检验医学与临床,2007,4(7):638-639. 被引量:5
  • 3Asbun J, Villarrea1 FJ. The pathogenesis of myocardial fibrosis in the setting of diabetic cardimyopathy[J]. Am Coil Cardio, 2006,47:693-700.
  • 4Lee DS,Gona P,Vasan RS,et al. Relation of disease pathogenesis and risk factors to heart failure with preserved or reduced ejection fraction: insights from the framingham heart study of the national heart,lung,and blood instiute[J]. Circulation, 2009,119 (24) : 3070-3077.
  • 5Semeniuk LM ,Kryski AJ,Severson DL. Echocardiographic assessment of cardiac function in diabetic db/db and transgenic db/dh-h GLUT4 mice [J]. Am J Physiol Heart Circ Physiol,2002,283 :H976-H982.
  • 6Chiu HC, Kovacs A, Blanton RM ,et al. Transgenic expression of fatty acid transport protein/in the heart causes lipotoxic cardiomyopathy [J]. C ire Res, 2005,96:225-233.
  • 7Weber NC,Toma O,Wolter JI, et al. The noble gas xenon induces phar- ma cologival preconditioning in the rat heart in vivo via induction of PKC-epsilon and p38 MAPK[J]. Brit J Pharmacol, 2005,144 ( 1 ) : 123- 132.
  • 8Connelly KA,Kelly DJ,Zhang Y,et al. Inhibition of protein kinase C- beta by ruboxistaurin preserves cardiac function and reduces extracel- lular matrix production in diabetic caardiomyopathy [J]. Circulation, 2009,2(2) : 129-137.
  • 9Kajstura J,Fiordaliso F,Andreoli AM. IGF-1 overexpression inhibits the development of diabetic cardiomyopathy and angiotenisin-mediated oxidative stress[J]. Diabetes ,2001,50(6) : 1414-1417.
  • 10Cai L. Diabetic cardiomyopathy and its prevention by metallothionein: experiment alevidence,possible mechanisms and clinical implications [J]. Curt Med Chem,2007,14(20) :2193-2203.

共引文献36

同被引文献80

引证文献8

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部